Replies to post #7984 on Ariad Pharmaceuticals Inc fka ARIA

[biotech_researcher]

You almost couldn't ask for better media coverage.. Although this is getting close to my Berger on the front cover of BusinessWeek topping process..

http://www.investorplace.com/40937/biotech-stock-to-buy-ariad-pharmaceuticals-inc-nasdaq-aria/

[qutrader]

"How much of that is "baked" into todays price? At $9 or $10 bucks, my answer is "not enough"."

Don, I'm the first one who believes we'll be at $15.00 by year-end, but we also have to consider that we were at two dollars and change a year ago or so. Therefore, the $7 or $8 increase has been significant and i believe attributable to most of the news that is already presumed by many on this board.

The only amounts I don't believe have been baked-in are the accelerated rate of Ponatinib and that it could be in the market in 2012; and any phase iii trials for Rida in other indications.

I believe all RIDA sarcoma news is baked-in - anything short of stellar news at ASCO or that otherwise results in any doubt as to FDA marketing approval will in fact bring down the stock. I don't see any further upside from positive news in that regard.